GSK said the U.S. Food and Drug Administration extended its review period for Blenrep combinations to treat patients with relapsed or refractory multiple myeloma.

Thanks to healthcare reform, the hurdles to securing reimbursement and technology add-on payments have risen. Boston will need to invest more in clinical studies to demonstrate superiority of outcomes ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

Curiosity, stress and peer influence are among the main reasons why young Malaysians get involved in substance abuse, says ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Mayo Clinic Jacksonville supports a blood test for to diagnose Alzheimer's while Baptist Health implanted its first atrial ...

No one doubts that rocket tests mean failures, but the question for Starship is this: Is it just having extended teething ...

Genomics & A*STAR GIS launch TISHUMAP study to advance AI-driven drug target discovery: Pleasanton, California Monday, July 21, 2025, 13:00 Hrs [IST] 10x Genomics, Inc., a lea ...

The Starlab space station, scheduled to launch on Starship in 2028, passed five development and design milestones, moving the ...

Hawley has rightly called the communist-run nation “the most significant threat of the 21st century,” and has introduced ...

When inflation and interest rates ticked upwards in the wake of Covid, the investment environment changed and share prices collapsed. That creates an opportunity for smart investors, says Jamie Ward ...

Veterans with PTSD find healing through ibogaine treatments in Mexico while Texas passes legislation to become a leader in ...